SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-98-004728
Filing Date
1998-05-08
Accepted
1998-05-08 00:00:00
Documents
1
Period of Report
1997-12-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 NYMOX PHARMACEUTICAL CORPORATION 20-F 146222
  Complete submission text file 0000950123-98-004728.txt   147678
Mailing Address 175 BOUCHARD, STE 100 DORVAL, QUEBEC CANADA, H9S 1B1 A8
Business Address 175 BOUCHARD, STE 100 DORVAL, QUEBEC CANADA H9S 1B1 A8 5146363122
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-12033 | Film No.: 98613340
SIC: 2835 In Vitro & In Vivo Diagnostic Substances